The Experts below are selected from a list of 69 Experts worldwide ranked by ideXlab platform

Raman Malhotra - One of the best experts on this subject based on the ideXlab platform.

  • Delayed Hypersensitivity reaction to restylane subq
    Orbit, 2011
    Co-Authors: Philip Oreilly, Raman Malhotra
    Abstract:

    Purpose: To report on 4 patients who developed Delayed Hypersensitivity reactions to Restylane® SubQ and their management. To our knowledge, no cases of Delayed Hypersensitivity to Restylane® SubQ have been previously reported.Methods: A retrospective case series of 4 patients who were treated with preperiosteal Restylane® SubQ to their cheeks, for facial volume augmentation. All 4 patients were subsequently referred with Delayed Hypersensitivity reactions over a 4-month period.Results: The Hypersensitivity reactions occurred from 1 week to 4 months’ post-cheek augmentation using Restylane® SubQ. All patients had previously (and some since) been treated with other non-animal stabilized hyaluronic acid (NASHA) products without adverse effect. Hyaluronidase led to fast and effective resolution in all cases, although 2 of the patients required repeat treatment.Conclusion: Hyaluronidase was effective at treating the inflammatory reaction and breaking up the retained Restylane® SubQ in all patients. Although R...

  • Delayed Hypersensitivity reaction to Restylane ® SubQ.
    Orbit, 2011
    Co-Authors: Philip O'reilly, Raman Malhotra
    Abstract:

    Purpose: To report on 4 patients who developed Delayed Hypersensitivity reactions to Restylane® SubQ and their management. To our knowledge, no cases of Delayed Hypersensitivity to Restylane® SubQ have been previously reported.Methods: A retrospective case series of 4 patients who were treated with preperiosteal Restylane® SubQ to their cheeks, for facial volume augmentation. All 4 patients were subsequently referred with Delayed Hypersensitivity reactions over a 4-month period.Results: The Hypersensitivity reactions occurred from 1 week to 4 months’ post-cheek augmentation using Restylane® SubQ. All patients had previously (and some since) been treated with other non-animal stabilized hyaluronic acid (NASHA) products without adverse effect. Hyaluronidase led to fast and effective resolution in all cases, although 2 of the patients required repeat treatment.Conclusion: Hyaluronidase was effective at treating the inflammatory reaction and breaking up the retained Restylane® SubQ in all patients. Although R...

D. Leroy - One of the best experts on this subject based on the ideXlab platform.

  • Delayed Hypersensitivity at the injection sites of a low‐molecular‐weight heparin
    Contact Dermatitis, 2006
    Co-Authors: A. Moreau, Anne Dompmartin, P. Esnault, M. Michel, D. Leroy
    Abstract:

    : We report a case of Delayed Hypersensitivity to a low-molecular-weight heparin. The patient presented with eczema at the site of subcutaneous injections and allergy tests confirmed the clinical diagnosis. There were positive tests with 3 low-molecular-weight heparins and unfractionated subcutaneous calcium heparin but negative with intravenous sodium heparin. Although Delayed Hypersensitivity to low-molecular-weight heparins is rare, the possibility of cross-allergy to unfractionated heparin could be a therapeutic problem for some patients.

A. Moreau - One of the best experts on this subject based on the ideXlab platform.

  • Delayed Hypersensitivity at the injection sites of a low‐molecular‐weight heparin
    Contact Dermatitis, 2006
    Co-Authors: A. Moreau, Anne Dompmartin, P. Esnault, M. Michel, D. Leroy
    Abstract:

    : We report a case of Delayed Hypersensitivity to a low-molecular-weight heparin. The patient presented with eczema at the site of subcutaneous injections and allergy tests confirmed the clinical diagnosis. There were positive tests with 3 low-molecular-weight heparins and unfractionated subcutaneous calcium heparin but negative with intravenous sodium heparin. Although Delayed Hypersensitivity to low-molecular-weight heparins is rare, the possibility of cross-allergy to unfractionated heparin could be a therapeutic problem for some patients.

Anne Dompmartin - One of the best experts on this subject based on the ideXlab platform.

  • Delayed Hypersensitivity at the injection sites of a low‐molecular‐weight heparin
    Contact Dermatitis, 2006
    Co-Authors: A. Moreau, Anne Dompmartin, P. Esnault, M. Michel, D. Leroy
    Abstract:

    : We report a case of Delayed Hypersensitivity to a low-molecular-weight heparin. The patient presented with eczema at the site of subcutaneous injections and allergy tests confirmed the clinical diagnosis. There were positive tests with 3 low-molecular-weight heparins and unfractionated subcutaneous calcium heparin but negative with intravenous sodium heparin. Although Delayed Hypersensitivity to low-molecular-weight heparins is rare, the possibility of cross-allergy to unfractionated heparin could be a therapeutic problem for some patients.

M. Michel - One of the best experts on this subject based on the ideXlab platform.

  • Delayed Hypersensitivity at the injection sites of a low‐molecular‐weight heparin
    Contact Dermatitis, 2006
    Co-Authors: A. Moreau, Anne Dompmartin, P. Esnault, M. Michel, D. Leroy
    Abstract:

    : We report a case of Delayed Hypersensitivity to a low-molecular-weight heparin. The patient presented with eczema at the site of subcutaneous injections and allergy tests confirmed the clinical diagnosis. There were positive tests with 3 low-molecular-weight heparins and unfractionated subcutaneous calcium heparin but negative with intravenous sodium heparin. Although Delayed Hypersensitivity to low-molecular-weight heparins is rare, the possibility of cross-allergy to unfractionated heparin could be a therapeutic problem for some patients.